Asbestos Diseases Research Institute - A New WHO Collaborating Center

Our plain-English summary of Asbestos Diseases Research Institute - A New WHO Collaborating Center, by Ken Takahashi (Industrial Health, 2021).

The study

• Author: Ken Takahashi
• Journal: Industrial Health
• Published: 2021;59(3):143-145
• Read it: PubMed · Publisher · Free full text

In plain English

This editorial reported no new research data. Its author, the institute's Director, described the Asbestos Diseases Research Institute (ADRI) in Sydney, Australia. ADRI was established in 2009 and has averaged 16 staff a year. The author described laboratory work on microRNAs in malignant pleural mesothelioma. It also described a biobank from mesothelioma and lung cancer patients, and nurse-led support for patients and families. Citing other sources, the author wrote that Australia carries one of the world's highest per capita burdens of asbestos-related diseases and was a major producer and exporter of blue asbestos (crocidolite) in the 1960s. The author wrote that although Australia totally banned asbestos in 2003, asbestos in place remains abundant in the community. The author added that the government cautions that all houses built or renovated before 1990 may contain it. After leading 2019 training workshops in the Philippines, Fiji and Indonesia, ADRI became in January 2021 the world's first WHO Collaborating Center for the Elimination of Asbestos Related Diseases. The author stated a belief that developed countries have a moral obligation to help developing countries prevent the same asbestos-disease tragedy from repeating.

We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.

What the study did and found

• Design: editorial (no original research data)
• Who was studied: No study population; the editorial describes the Asbestos Diseases Research Institute (ADRI) in Sydney, Australia, and was written by its Director
• Exposure: No exposure was studied; the editorial mentions Australia's past production and export of blue asbestos (crocidolite) and asbestos still present in the community
• Main results:
  • The editorial states that ADRI was established in 2009
  • The editorial states that ADRI functions as an independent medical research institute
  • The editorial states that ADRI has had a yearly average of 16 staff
  • The editorial describes ADRI's preclinical research on microRNAs in malignant pleural mesothelioma
  • The editorial states that the ADRI Biobank holds biospecimens and clinical data from mesothelioma and lung cancer patients
  • The editorial states that two registered nurses provide clinical knowledge and social support to mesothelioma patients, families and carers
  • Citing another source, the author states that Australia has one of the world's highest per capita burdens of asbestos-related diseases
  • The author states that asbestos was totally banned in Australia in 2003
  • The author states that asbestos in place remains abundant in the community, and that the government cautions that all houses built or renovated before 1990 may contain asbestos
  • The editorial states that ADRI led training workshops in the Philippines, Fiji and Indonesia in 2019
  • The editorial states that in January 2021 ADRI became the world's first WHO Collaborating Center for the Elimination of Asbestos Related Diseases
• The authors' conclusion: The author stated a belief that developed countries have a moral obligation to assist developing countries in preventing the same tragedy (asbestos-related diseases on a large scale) from repeating

Topics

The National Library of Medicine indexes this study under subjects our site covers: Asbestosis, Mesothelioma.

Related studies

• Comments on the Health Effects Institute-Asbestos Research (HEI-AR) report: "Asbestos in public and commercial buildings," with emphasis on risk assessment methods used — T.D. Sterling, C.W. Collett, et al. (1993)
• Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation — A.S. Tsao, O.W. Lindwasser, et al. (2018)
• The Use of Radiation Therapy for the Treatment of Malignant Pleural Mesothelioma: Expert Opinion from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation — D.R. Gomez, A. Rimner, et al. (2019)
• A Proposed System Toward Standardizing Surgical-Based Treatments for Malignant Pleural Mesothelioma, From the Joint National Cancer Institute-International Association for the Study of Lung Cancer-Mesothelioma Applied Research Foundation Taskforce — J.S. Friedberg, M.J. Culligan, et al. (2019)
• The Dutch Institute for Asbestos Victims — Y.R. Waterman, M.G. Peeters (2004)
• Finnish Institute of Occupational Health (FIOH): prevention and detection of asbestos-related diseases, 1987-2005 — M.S. Huuskonen, J. Rantanen (2006)

Browse more research in Industrial Health, or return to medical research.